Advertisement

Immunotherapy

  • International Union Against Cancer
Part of the International Union Against Cancer / Union Internationale Contre le Cancer book series (UICCI)

Abstract

The impact of immunotherapy is difficult to evaluate at the present time. Most likely, developments of greater consequence still lie in the future. In contrast, studies on the immunobiology of cancer have been more encouraging. The determination of immune competence prior to and during therapy has been found to be of some prognostic value.103 Since preliminary studies have shown that the overall therapeutic effect on both the tumour response and recurrence rate may depend on both immune competence and the cytotoxic therapy, optimal therapy planning may require an evaluation of the individual patient’s immune status. Confirmation of the original results103 is currently being widely tested in many laboratories. It is anticipated that routine laboratory test systems will be developed that permit a prognostic correlation between cell-mediated immune responses and the result of therapy.

Keywords

Immune Response Recurrence Rate Tumour Response Neoplastic Disease Original Results103 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • International Union Against Cancer
    • 1
  1. 1.GenevaSwitzerland

Personalised recommendations